Global leader in AI-powered breast health solutions, now part of DeepHealth, providing clinically proven solutions for cancer detection, density assessment, and personalized risk evaluation.
Global leader in AI-powered breast health solutions, now part of DeepHealth, providing clinically proven solutions for cancer detection, density assessment, and personalized risk evaluation.
Suite of clinically proven AI-powered solutions for cancer detection, density assessment, and personalized risk evaluation; includes the ProFound Scorecard.
Solution that simplifies and standardizes breast density reporting and stratification by analyzing 2D or 3D mammogram images to deliver patient-specific breast density assessments.
Image-based short-term risk evaluation solution providing a 1 or 2 year probability score for developing breast cancer; CE Marked and Health Canada Licensed, not FDA Cleared, av...
“My MQSA numbers are the best they’ve ever been. My productivity is as high as it has ever been, with this algorithm and with this suite of tools here. Everybody wants you to do a better job and work faster, and this has allowed me to do it. Mark Traill, MDBreast Radiologist, University of Michigan Health-West”
Mark Traill, MDBreast Radiologist, University of Michigan Health-WestProFound Breast Health Suite customer
“Adopting ProFound AI was straightforward. It increases our comfort level knowing that the technology is reading every image, or slice, and it’s reassuring knowing that this technology will help us not miss a cancer. I typically will read the images without ProFound AI first, just to get a gut impression of the case, but when I turn ProFound AI on, it gives me added peace of mind knowing that the technology will alert me to look at certain images more closely.”
Gabriele PedicelliiCAD, Inc. customer
“Adopting ProFound AI was a seamless process that offered immediate benefits to our radiologists and patients, and we have gained additional efficiencies since then.”
David HarrisoniCAD, Inc. customer
ProFound AI Detection
Marine Park Radiology adopted ProFound AI for DBT in 2018. iCAD’s case reports a 50% increase in cancer pickup with the combination of AI and 3D tomosynthesis, alongside shorter reading times and improved confidence.
Swedish-American Hospital installed PowerLook Density Assessment at its Center for Women in December 2016. iCAD’s story reports easier density categorization, improved workflow, and immediate answers to patients’…
Southwest Diagnostic Imaging Center used ProFound AI during its transition to 3D mammography. In iCAD’s story, Dr. Katherine Hall reported a 25–50% reduction in her reading time and support for moving to an all-3D…
DeepHealth Receives FDA Clearances for Breast Imaging AI Tools
DeepHealth, a subsidiary of RadNet, Inc., received FDA 510(k) clearances for two new functionalities within its Breast Suite: a Breast Arterial Calcification (BAC) Assessment tool to identify indicators of cardiovascular disease, and prior exam integration for its Mammo Dx platform to improve lesion tracking. These tools are designed to assist radiologists by providing automated assessments during standard breast imaging and are now commercially available in the United States.
